Small Molecule CMO/CDMO Market - Global Small Molecule CMO CDMO Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product,By Service, By Company Size,By Scale of Operation, By Geographic Coverage and By Company)

Description

The global Small Molecule CMO/CDMO market is witnessing remarkable growth as pharmaceutical and biotech companies increasingly turn to contract manufacturing and development partners to optimize drug production. Valued at US$81.2 billion in 2025, the market is projected to reach US$118.1 billion by 2032, registering a CAGR of 5.5%. The rising demand for small molecule therapeutics, along with the need for flexible, cost-efficient, and high-quality manufacturing solutions, is driving the adoption of CMO/CDMO services worldwide.

Market Insights

CMO/CDMO providers play a critical role in the pharmaceutical supply chain, offering comprehensive services ranging from process development and analytical testing to regulatory support, scale-up, and commercial manufacturing. Outsourcing allows pharmaceutical companies to focus on innovation and reduce capital expenditures while leveraging the expertise and specialized capabilities of contract partners. The market is shifting from traditional in-house production toward collaboration with CMOs/CDMOs, a trend accelerated by the increasing complexity of drug molecules, regulatory demands, and the pressure to reduce time-to-market.

Drivers

The growth of the small molecule CMO/CDMO market is driven by several factors:

1. Outsourcing Trend Acceleration: Pharmaceutical companies are increasingly outsourcing API production and finished dosage manufacturing to control costs, manage capacity, and improve operational efficiency.
2. Expansion of Small Molecule Drug Pipeline: Rising development of small molecule drugs, particularly in oncology, neurology, and rare disease therapies, is fueling demand for contract services.
3. Advanced Manufacturing Technologies: CMOs/CDMOs are integrating continuous processing, high-potency API handling, and other innovative technologies, enabling more efficient and specialized production.
4. Complex Regulatory Environment: Increasingly stringent compliance requirements are prompting pharmaceutical firms to collaborate with experienced contract manufacturers capable of navigating regulatory pathways effectively.

Business Opportunities

The market presents significant opportunities for both established players and new entrants. Companies offering integrated solutions across the drug development lifecycle-from early-stage process development to commercial manufacturing-are poised for success. Strategic partnerships, capacity expansions, and acquisitions allow providers to broaden service portfolios, enhance capabilities, and serve emerging client needs. Additionally, the growing focus on high-potency APIs and personalized therapies is creating opportunities for providers with specialized manufacturing capabilities.

Regional Analysis

The market exhibits distinct regional characteristics:

North America remains the largest market, driven by a mature pharmaceutical industry, strong R&D infrastructure, and widespread adoption of outsourcing models.
Europe is a well-established market, featuring leading CMOs/CDMOs, strict regulatory standards, and high demand for specialized APIs and manufacturing services.
Asia Pacific is emerging rapidly, benefiting from cost advantages, supportive government policies, and growing foreign investment in pharmaceutical manufacturing.
Latin America and Middle East & Africa are developing markets with expanding healthcare infrastructure and increasing pharmaceutical production capabilities.

Key Players

The global small molecule CMO/CDMO market is competitive and fragmented, with leading players driving technological innovation and capacity expansion. Key market participants include:

Lonza
Thermo Fisher Scientific (Patheon)
Catalent, Inc.
WuXi AppTec
Siegfried Holding AG
Recipharm AB
Piramal Pharma Solutions
Pfizer CentreOne
Eurofins Scientific
Cambrex Corporation
Almac Group
Ajinomoto Bio-Pharma Services
AGC Inc. (AGC Pharma Chemicals)
CordenPharma
Aenova Group
Others

These companies continue to strengthen their market positions through strategic collaborations, capacity expansions, and technological advancements.

Market Segmentation

The Global Small Molecule CMO/CDMO Market is segmented as follows:

By Product

Standard API
HP API

By Service

Process Development
Analytical Method Development
GMP Manufacturing Service
Scale-up and Tech Transfer
Regulatory Assistance
Fill-finish Services

By Company Size

Small
Mid-sized
Large

By Scale of Operation

Clinical
Commercial

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

1. Executive Summary

1.1. Global Small Molecule CMO/CDMO Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Fiver Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2024-2032
- 2.9.2. Price Impact Factors

3. Global Small Molecule CMO/CDMO Market Outlook, 2019-2032

3.1. Global Small Molecule CMO/CDMO Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
- 3.1.1. Standard API
- 3.1.2. HP API
3.2. Global Small Molecule CMO/CDMO Market Outlook, by Service, Value (US$ Bn), 2019-2032
- 3.2.1. Process Development
- 3.2.2. Analytical Method Development
- 3.2.3. GMP Manufacturing Service
- 3.2.4. Scale-up and Tech Transfer
- 3.2.5. Regulatory Assistance
- 3.2.6. Fill-finish Services
3.3. Global Small Molecule CMO/CDMO Market Outlook, by Company Size, Value (US$ Bn), 2019-2032
- 3.3.1. Small
- 3.3.2. Mid-sized
- 3.3.3. Large
3.4. Global Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, Value (US$ Bn), 2019-2032
- 3.4.1. Clinical
- 3.4.2. Commercial
3.5. Global Small Molecule CMO/CDMO Market Outlook, by Region, Value (US$ Bn), 2019-2032
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa

4. North America Small Molecule CMO/CDMO Market Outlook, 2019-2032

4.1. North America Small Molecule CMO/CDMO Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
- 4.1.1. Standard API
- 4.1.2. HP API
4.2. North America Small Molecule CMO/CDMO Market Outlook, by Service, Value (US$ Bn), 2019-2032
- 4.2.1. Process Development
- 4.2.2. Analytical Method Development
- 4.2.3. GMP Manufacturing Service
- 4.2.4. Scale-up and Tech Transfer
- 4.2.5. Regulatory Assistance
- 4.2.6. Fill-finish Services
4.3. North America Small Molecule CMO/CDMO Market Outlook, by Company Size, Value (US$ Bn), 2019-2032
- 4.3.1. Small
- 4.3.2. Mid-sized
- 4.3.3. Large
4.4. North America Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, Value (US$ Bn), 2019-2032
- 4.4.1. Clinical
- 4.4.2. Commercial
4.5. North America Small Molecule CMO/CDMO Market Outlook, by Country, Value (US$ Bn), 2019-2032
- 4.5.1. U.S. Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 4.5.2. U.S. Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 4.5.3. U.S. Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 4.5.4. U.S. Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 4.5.5. Canada Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 4.5.6. Canada Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 4.5.7. Canada Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 4.5.8. Canada Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe Small Molecule CMO/CDMO Market Outlook, 2019-2032

5.1. Europe Small Molecule CMO/CDMO Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
- 5.1.1. Standard API
- 5.1.2. HP API
5.2. Europe Small Molecule CMO/CDMO Market Outlook, by Service, Value (US$ Bn), 2019-2032
- 5.2.1. Process Development
- 5.2.2. Analytical Method Development
- 5.2.3. GMP Manufacturing Service
- 5.2.4. Scale-up and Tech Transfer
- 5.2.5. Regulatory Assistance
- 5.2.6. Fill-finish Services
5.3. Europe Small Molecule CMO/CDMO Market Outlook, by Company Size, Value (US$ Bn), 2019-2032
- 5.3.1. Small
- 5.3.2. Mid-sized
- 5.3.3. Large
5.4. Europe Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, Value (US$ Bn), 2019-2032
- 5.4.1. Clinical
- 5.4.2. Commercial
5.5. Europe Small Molecule CMO/CDMO Market Outlook, by Country, Value (US$ Bn), 2019-2032
- 5.5.1. Germany Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 5.5.2. Germany Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 5.5.3. Germany Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 5.5.4. Germany Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 5.5.5. Italy Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 5.5.6. Italy Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 5.5.7. Italy Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 5.5.8. Italy Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 5.5.9. France Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 5.5.10. France Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 5.5.11. France Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 5.5.12. France Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 5.5.13. U.K. Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 5.5.14. U.K. Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 5.5.15. U.K. Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 5.5.16. U.K. Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 5.5.17. Spain Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 5.5.18. Spain Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 5.5.19. Spain Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 5.5.20. Spain Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 5.5.21. Russia Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 5.5.22. Russia Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 5.5.23. Russia Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 5.5.24. Russia Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 5.5.25. Rest of Europe Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 5.5.26. Rest of Europe Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 5.5.27. Rest of Europe Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 5.5.28. Rest of Europe Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Small Molecule CMO/CDMO Market Outlook, 2019-2032

6.1. Asia Pacific Small Molecule CMO/CDMO Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
- 6.1.1. Standard API
- 6.1.2. HP API
6.2. Asia Pacific Small Molecule CMO/CDMO Market Outlook, by Service, Value (US$ Bn), 2019-2032
- 6.2.1. Process Development
- 6.2.2. Analytical Method Development
- 6.2.3. GMP Manufacturing Service
- 6.2.4. Scale-up and Tech Transfer
- 6.2.5. Regulatory Assistance
- 6.2.6. Fill-finish Services
6.3. Asia Pacific Small Molecule CMO/CDMO Market Outlook, by Company Size, Value (US$ Bn), 2019-2032
- 6.3.1. Small
- 6.3.2. Mid-sized
- 6.3.3. Large
6.4. Asia Pacific Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, Value (US$ Bn), 2019-2032
- 6.4.1. Clinical
- 6.4.2. Commercial
6.5. Asia Pacific Small Molecule CMO/CDMO Market Outlook, by Country, Value (US$ Bn), 2019-2032
- 6.5.1. China Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 6.5.2. China Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 6.5.3. China Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 6.5.4. China Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 6.5.5. Japan Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 6.5.6. Japan Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 6.5.7. Japan Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 6.5.8. Japan Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 6.5.9. South Korea Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 6.5.10. South Korea Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 6.5.11. South Korea Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 6.5.12. South Korea Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 6.5.13. India Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 6.5.14. India Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 6.5.15. India Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 6.5.16. India Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 6.5.17. Southeast Asia Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 6.5.18. Southeast Asia Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 6.5.19. Southeast Asia Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 6.5.20. Southeast Asia Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 6.5.21. Rest of SAO Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 6.5.22. Rest of SAO Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 6.5.23. Rest of SAO Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 6.5.24. Rest of SAO Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America Small Molecule CMO/CDMO Market Outlook, 2019-2032

7.1. Latin America Small Molecule CMO/CDMO Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
- 7.1.1. Standard API
- 7.1.2. HP API
7.2. Latin America Small Molecule CMO/CDMO Market Outlook, by Service, Value (US$ Bn), 2019-2032
- 7.2.1. Process Development
- 7.2.2. Analytical Method Development
- 7.2.3. GMP Manufacturing Service
- 7.2.4. Scale-up and Tech Transfer
- 7.2.5. Regulatory Assistance
- 7.2.6. Fill-finish Services
7.3. Latin America Small Molecule CMO/CDMO Market Outlook, by Company Size, Value (US$ Bn), 2019-2032
- 7.3.1. Small
- 7.3.2. Mid-sized
- 7.3.3. Large
7.4. Latin America Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, Value (US$ Bn), 2019-2032
- 7.4.1. Clinical
- 7.4.2. Commercial
7.5. Latin America Small Molecule CMO/CDMO Market Outlook, by Country, Value (US$ Bn), 2019-2032
- 7.5.1. Brazil Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 7.5.2. Brazil Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 7.5.3. Brazil Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 7.5.4. Brazil Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 7.5.5. Mexico Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 7.5.6. Mexico Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 7.5.7. Mexico Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 7.5.8. Mexico Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 7.5.9. Argentina Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 7.5.10. Argentina Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 7.5.11. Argentina Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 7.5.12. Argentina Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 7.5.13. Rest of LATAM Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 7.5.14. Rest of LATAM Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 7.5.15. Rest of LATAM Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 7.5.16. Rest of LATAM Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Small Molecule CMO/CDMO Market Outlook, 2019-2032

8.1. Middle East & Africa Small Molecule CMO/CDMO Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
- 8.1.1. Standard API
- 8.1.2. HP API
8.2. Middle East & Africa Small Molecule CMO/CDMO Market Outlook, by Service, Value (US$ Bn), 2019-2032
- 8.2.1. Process Development
- 8.2.2. Analytical Method Development
- 8.2.3. GMP Manufacturing Service
- 8.2.4. Scale-up and Tech Transfer
- 8.2.5. Regulatory Assistance
- 8.2.6. Fill-finish Services
8.3. Middle East & Africa Small Molecule CMO/CDMO Market Outlook, by Company Size, Value (US$ Bn), 2019-2032
- 8.3.1. Small
- 8.3.2. Mid-sized
- 8.3.3. Large
8.4. Middle East & Africa Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, Value (US$ Bn), 2019-2032
- 8.4.1. Clinical
- 8.4.2. Commercial
8.5. Middle East & Africa Small Molecule CMO/CDMO Market Outlook, by Country, Value (US$ Bn), 2019-2032
- 8.5.1. GCC Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 8.5.2. GCC Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 8.5.3. GCC Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 8.5.4. GCC Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 8.5.5. South Africa Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 8.5.6. South Africa Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 8.5.7. South Africa Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 8.5.8. South Africa Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 8.5.9. Egypt Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 8.5.10. Egypt Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 8.5.11. Egypt Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 8.5.12. Egypt Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 8.5.13. Nigeria Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 8.5.14. Nigeria Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 8.5.15. Nigeria Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 8.5.16. Nigeria Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
- 8.5.17. Rest of Middle East Small Molecule CMO/CDMO Market Outlook, by Product Type, 2019-2032
- 8.5.18. Rest of Middle East Small Molecule CMO/CDMO Market Outlook, by Service, 2019-2032
- 8.5.19. Rest of Middle East Small Molecule CMO/CDMO Market Outlook, by Company Size, 2019-2032
- 8.5.20. Rest of Middle East Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, 2019-2032
8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2024
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Lonza
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Developments
- 9.4.2. Thermo Fisher Scientific (Patheon)
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Developments
- 9.4.3. Catalent, Inc.
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Developments
- 9.4.4. WuXi AppTec
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Developments
- 9.4.5. Siegfried Holding AG
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Developments
- 9.4.6. Recipharm AB
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Developments
- 9.4.7. Piramal Pharma Solutions
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Developments
- 9.4.8. Pfizer CentreOne
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Developments
- 9.4.9. Eurofins Scientific
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Developments
- 9.4.10. Cambrex Corporation
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Product Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Developments

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations